UnknownNot Applicable

Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

144 participantsStarted 2016-12

Plain-language summary

Based on multi-center clinical research resources, a large-scale prospective cohort study will be conduted to make a more accurate diagnosis and intervention plan of Non-immune fetal hydrops (NIFH), and then establish NIFH accurate treatment strategy which is suitable for China's national conditions.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cases corresponding to diagnosis standards * Willing to accept the regular follow-up Exclusion Criteria: * Immune hydrops fetalis * Multiple pregnancy, except for twin-to-twin transfusion syndrome IV

What they're measuring

Neonatal mortality

Timeframe: 1 year

Trial details

NCT IDNCT02956564

SponsorShanghai First Maternity and Infant Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08

View on ClinicalTrials.gov More Fetal Hydrops trials